{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:57:54Z","timestamp":1768971474428,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T00:00:00Z","timestamp":1402876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T00:00:00Z","timestamp":1402876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Administration of several cardiovascular drugs has an effect on dementia. We aimed to investigate whether there are differences in the use of cardiovascular medication between different dementia disorders.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We obtained information about dementia patients from the Swedish Dementia Registry. Patients were diagnosed with one of these dementia disorders: Alzheimer\u2019s disease (n\u2009=\u20098,139), mixed dementia (n\u2009=\u20095,203), vascular dementia (n\u2009=\u20094,982), Lewy body dementia (n\u2009=\u2009605), frontotemporal dementia (n\u2009=\u2009409) and Parkinson\u2019s disease dementia (n\u2009=\u2009405). Multivariate logistic regression analysis was performed to investigate the association between use of cardiovascular medication and dementia disorders, after adjustment for age, gender, living alone, cognitive status and total number of drugs (a proxy for overall co-morbidity).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Seventy percent of all the dementia patients used cardiovascular medication. Use of cardiovascular drugs is common in patients with vascular and mixed dementia. Male gender, higher age, slightly better cognitive status and living with another person was associated with use of cardiovascular medication.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Cardiovascular medication is used extensively across dementia disorders and particularly in vascular and mixed dementia. Future research should investigate the tolerability and effectiveness of these drugs in the different dementia disorders.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/alzrt264","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T17:59:41Z","timestamp":1402941581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry"],"prefix":"10.1186","volume":"6","author":[{"given":"Pavla","family":"Cermakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed-Mohammad","family":"Fereshtehnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Johnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Eriksdotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Religa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,16]]},"reference":[{"key":"220_CR1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","volume":"322","author":"M Kivipelto","year":"2001","unstructured":"Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study. Bmj. 2001, 322: 1447-1451. 10.1136\/bmj.322.7300.1447.","journal-title":"Bmj"},{"key":"220_CR2","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","volume":"62","author":"M Kivipelto","year":"2005","unstructured":"Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005, 62: 1556-1560.","journal-title":"Arch Neurol"},{"key":"220_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2165\/00023210-200216070-00001","volume":"16","author":"M Kivipelto","year":"2002","unstructured":"Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H: Hypertension and hypercholesterolaemia as risk factors for Alzheimer\u2019s disease: potential for pharmacological intervention. CNS drugs. 2002, 16: 435-444. 10.2165\/00023210-200216070-00001.","journal-title":"CNS drugs"},{"key":"220_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/01.STR.28.2.316","volume":"28","author":"A Ott","year":"1997","unstructured":"Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A: Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke J Cerebr Circ. 1997, 28: 316-321. 10.1161\/01.STR.28.2.316.","journal-title":"Stroke J Cerebr Circ"},{"key":"220_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/archinte.166.9.1003","volume":"166","author":"C Qiu","year":"2006","unstructured":"Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L: Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006, 166: 1003-1008. 10.1001\/archinte.166.9.1003.","journal-title":"Arch Intern Med"},{"key":"220_CR6","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/jgs.12415","volume":"61","author":"ME Soto","year":"2013","unstructured":"Soto ME, van Kan GA, Nourhashemi F, Gillette-Guyonnet S, Cesari M, Cantet C, Rolland Y, Vellas B: Angiotensin-converting enzyme inhibitors and Alzheimer\u2019s disease progression in older adults: results from the Reseau sur la Maladie d\u2019Alzheimer Francais cohort. J Am Geriatr Soc. 2013, 61: 1482-1488. 10.1111\/jgs.12415.","journal-title":"J Am Geriatr Soc"},{"key":"220_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","volume":"81","author":"S Yasar","year":"2013","unstructured":"Yasar S, Xia J, Yao W, Furberg CD, Xue QL, Mercado CI, Fitzpatrick AL, Fried LP, Kawas CH, Sink KM, Williamson JD, DeKosky ST, Carlson MC, Ginkgo\u00a0Evaluation\u00a0of\u00a0Memory\u2009(GEM)\u2009StudyInvestigators: Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology. 2013, 81: 896-903. 10.1212\/WNL.0b013e3182a35228.","journal-title":"Neurology"},{"key":"220_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/gps.2638","volume":"26","author":"SP Kennelly","year":"2011","unstructured":"Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA: Demonstration of safety in Alzheimer\u2019s patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study. Int J Geriatr Psychiat. 2011, 26: 1038-1045. 10.1002\/gps.2638.","journal-title":"Int J Geriatr Psychiat"},{"key":"220_CR9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","volume":"63","author":"AS Khachaturian","year":"2006","unstructured":"Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC: Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006, 63: 686-692. 10.1001\/archneur.63.5.noc60013.","journal-title":"Arch Neurol"},{"key":"220_CR10","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1212\/WNL.0b013e3182a351d4","volume":"81","author":"RP Gelber","year":"2013","unstructured":"Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, White LR: Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study. Neurology. 2013, 81: 888-895. 10.1212\/WNL.0b013e3182a351d4.","journal-title":"Neurology"},{"key":"220_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","volume":"41","author":"TS Anekonda","year":"2011","unstructured":"Anekonda TS, Quinn JF, Harris C, Frahler K, Wadsworth TL, Woltjer RL: L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer\u2019s disease. Neurobiol Dis. 2011, 41: 62-70. 10.1016\/j.nbd.2010.08.020.","journal-title":"Neurobiol Dis"},{"key":"220_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/00207459708986392","volume":"92","author":"M Popovic","year":"1997","unstructured":"Popovic M, Caballero-Bleda M, Popovic N, Bokonjic D, Dobric S: Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer\u2019s disease in rats. Int J Neurosci. 1997, 92: 79-93. 10.3109\/00207459708986392.","journal-title":"Int J Neurosci"},{"key":"220_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1532-5415.2007.01071.x","volume":"55","author":"JV Agostini","year":"2007","unstructured":"Agostini JV, Tinetti ME, Han L, McAvay G, Foody JM, Concato J: Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc. 2007, 55: 420-425. 10.1111\/j.1532-5415.2007.01071.x.","journal-title":"J Am Geriatr Soc"},{"key":"220_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","volume":"352","author":"F Forette","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998, 352: 1347-1351. 10.1016\/S0140-6736(98)03086-4.","journal-title":"Lancet"},{"key":"220_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","volume":"21","author":"H Lithell","year":"2003","unstructured":"Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group: The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003, 21: 875-886. 10.1097\/00004872-200305000-00011.","journal-title":"J Hypertens"},{"key":"220_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00424-012-1102-2","volume":"465","author":"JW Wright","year":"2013","unstructured":"Wright JW, Harding JW: The brain renin\u2013angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Archiv Eur J Physiol. 2013, 465: 133-151. 10.1007\/s00424-012-1102-2.","journal-title":"Pflugers Archiv Eur J Physiol"},{"key":"220_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1517\/13543784.2013.812631","volume":"22","author":"EL Ashby","year":"2013","unstructured":"Ashby EL, Kehoe PG: Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer\u2019s disease. Expert Opin Invest Drugs. 2013, 22: 1229-1242. 10.1517\/13543784.2013.812631.","journal-title":"Expert Opin Invest Drugs"},{"key":"220_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cyto.2012.08.016","volume":"60","author":"C Bay-Richter","year":"2012","unstructured":"Bay-Richter C, Hallberg L, Ventorp F, Janelidze S, Brundin L: Aldosterone synergizes with peripheral inflammation to induce brain IL-1\u03b2 expression and depressive-like effects. Cytokine. 2012, 60: 749-754. 10.1016\/j.cyto.2012.08.016.","journal-title":"Cytokine"},{"key":"220_CR19","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1096\/fj.11-182873","volume":"25","author":"YF Dong","year":"2011","unstructured":"Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S: Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer\u2019s disease. FASEB J Official Public Feder Am Soc Exp Biol. 2011, 25: 2911-2920. 10.1096\/fj.11-182873.","journal-title":"FASEB J Official Public Feder Am Soc Exp Biol"},{"key":"220_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","volume":"1352","author":"K Yamada","year":"2010","unstructured":"Yamada K, Uchida S, Takahashi S, Takayama M, Nagata Y, Suzuki N, Shirakura S, Kanda T: Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer\u2019s disease. Brain Res. 2010, 1352: 176-186.","journal-title":"Brain Res"},{"key":"220_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3233\/JAD-131694","volume":"40","author":"R O\u2019Caoimh","year":"2014","unstructured":"O\u2019Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, Kehoe PG, Guyatt G, Molloy DW: Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with alzheimer\u2019s disease. J Alzheimers Dis. 2014, 40: 595-603.","journal-title":"J Alzheimers Dis"},{"key":"220_CR22","doi-asserted-by":"publisher","first-page":"b5465","DOI":"10.1136\/bmj.b5465","volume":"340","author":"NC Li","year":"2010","unstructured":"Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B: Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010, 340: b5465-10.1136\/bmj.b5465.","journal-title":"BMJ"},{"key":"220_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000099037","volume":"23","author":"B Zhou","year":"2007","unstructured":"Zhou B, Teramukai S, Fukushima M: Prevention and treatment of dementia or Alzheimer\u2019s disease by statins: a meta-analysis. Dement Geriatr Cogn Disord. 2007, 23: 194-201. 10.1159\/000099037.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"220_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.archger.2008.06.005","volume":"49","author":"H Brunnstrom","year":"2009","unstructured":"Brunnstrom H, Gustafson L, Passant U, Englund E: Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports. Arch Gerontol Geriatr. 2009, 49: 146-149. 10.1016\/j.archger.2008.06.005.","journal-title":"Arch Gerontol Geriatr"},{"key":"220_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1749-6632.2000.tb06408.x","volume":"903","author":"K Rockwood","year":"2000","unstructured":"Rockwood K, Macknight C, Wentzel C, Black S, Bouchard R, Gauthier S, Feldman H, Hogan D, Kertesz A, Montgomery P: The diagnosis of \u2018mixed\u2019 dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann NY Acad Sci. 2000, 903: 522-528. 10.1111\/j.1749-6632.2000.tb06408.x.","journal-title":"Ann NY Acad Sci"},{"key":"220_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp.74.6.720","volume":"74","author":"T Rahkonen","year":"2003","unstructured":"Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R: Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry. 2003, 74: 720-724. 10.1136\/jnnp.74.6.720.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"220_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ageing\/afi190","volume":"34","author":"J Zaccai","year":"2005","unstructured":"Zaccai J, McCracken C, Brayne C: A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005, 34: 561-566. 10.1093\/ageing\/afi190.","journal-title":"Age Ageing"},{"key":"220_CR28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, et al: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005, 65: 1863-1872. 10.1212\/01.wnl.0000187889.17253.b1.","journal-title":"Neurology"},{"key":"220_CR29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-121819","volume":"35","author":"P Imfeld","year":"2013","unstructured":"Imfeld P, Brauchli Pernus YB, Jick SS, Meier CR: Epidemiology, co-morbidities, and medication use of patients with Alzheimer\u2019s disease or vascular dementia in the UK. JAD. 2013, 35: 565-573.","journal-title":"JAD"},{"key":"220_CR30","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/j.1532-5415.1994.tb06590.x","volume":"42","author":"J Holstein","year":"1994","unstructured":"Holstein J, Chatellier G, Piette F, Moulias R: Prevalence of associated diseases in different types of dementia among elderly institutionalized patients: analysis of 3447 records. J Am Geriatr Soc. 1994, 42: 972-977.","journal-title":"J Am Geriatr Soc"},{"key":"220_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/153331750201700210","volume":"17","author":"M Sanderson","year":"2002","unstructured":"Sanderson M, Wang J, Davis DR, Lane MJ, Cornman CB, Fadden MK: Co-morbidity associated with dementia. Am J Alzheimers Dis Other Dement. 2002, 17: 73-78. 10.1177\/153331750201700210.","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"220_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/WNL.58.1.62","volume":"58","author":"JW Hill","year":"2002","unstructured":"Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H: Alzheimer\u2019s disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 2002, 58: 62-70. 10.1212\/WNL.58.1.62.","journal-title":"Neurology"},{"key":"220_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1047-2797(01)00244-7","volume":"12","author":"ED Eaker","year":"2002","unstructured":"Eaker ED, Mickel SF, Chyou PH, Mueller-Rizner NJ, Slusser JP: Alzheimer\u2019s disease or other dementia and medical care utilization. Ann Epidemiol. 2002, 12: 39-45. 10.1016\/S1047-2797(01)00244-7.","journal-title":"Ann Epidemiol"},{"key":"220_CR34","first-page":"2014","volume":"2014","author":"SM Fereshtehnejad","year":"2014","unstructured":"Fereshtehnejad SM, Jonhell K, Eriksdotter M: Anti-dementia drugs and co-medication amongst patients with alzheimer\u2019s disease: Investigating real-world drug use in clinical practice using the Swedish dementia quality registry (SveDem). Drugs Aging. 2014, 2014: 2014-","journal-title":"Drugs Aging"},{"key":"220_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/jnnp.2006.102343","volume":"78","author":"LM Allan","year":"2007","unstructured":"Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA: Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry. 2007, 78: 671-677.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"220_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nrl.2013.02.010","volume":"29","author":"A Robles Bayon","year":"2014","unstructured":"Robles Bayon A, Gude Sampedro F, Torregrosa Quesada JM: Bradycardia in frontotemporal dementia. Neurologia. 2014, 29: 76-85. 10.1016\/j.nrl.2013.02.010.","journal-title":"Neurologia"},{"key":"220_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.25445","volume":"28","author":"RB Postuma","year":"2013","unstructured":"Postuma RB, Gagnon JF, Pelletier A, Montplaisir J: Prodromal autonomic symptoms and signs in Parkinson\u2019s disease and dementia with Lewy bodies. Mov. Disord Official J Mov Disord Soc. 2013, 28: 597-604. 10.1002\/mds.25445.","journal-title":"Mov. Disord Official J Mov Disord Soc"},{"key":"220_CR38","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1111\/jgs.12553","volume":"61","author":"RH Affoo","year":"2013","unstructured":"Affoo RH, Foley N, Rosenbek J, Kevin Shoemaker J, Martin RE: Swallowing dysfunction and autonomic nervous system dysfunction in alzheimer\u2019s disease: a scoping review of the evidence. J Am Geriatr Soc. 2013, 61: 2203-2213. 10.1111\/jgs.12553.","journal-title":"J Am Geriatr Soc"},{"key":"220_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2318-13-121","volume":"13","author":"T Fiss","year":"2013","unstructured":"Fiss T, Thyrian JR, Wucherer D, Assmann G, Kilimann I, Teipel SJ, Hoffmann W: Medication management for people with dementia in primary care: description of implementation in the DelpHi study. BMC Geriatr. 2013, 13: 121-10.1186\/1471-2318-13-121.","journal-title":"BMC Geriatr"},{"key":"220_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2165\/0002512-200825120-00005","volume":"25","author":"S Arlt","year":"2008","unstructured":"Arlt S, Lindner R, Rosler A, von Renteln-Kruse W: Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging. 2008, 25: 1033-1047. 10.2165\/0002512-200825120-00005.","journal-title":"Drugs Aging"},{"key":"220_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000329862","volume":"32","author":"S Alladi","year":"2011","unstructured":"Alladi S, Mekala S, Chadalawada SK, Jala S, Mridula R, Kaul S: Subtypes of dementia: a study from a memory clinic in India. Dement Geriatr Cogn Dis. 2011, 32: 32-38. 10.1159\/000329862.","journal-title":"Dement Geriatr Cogn Dis"},{"key":"220_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000348408","volume":"35","author":"K Johnell","year":"2013","unstructured":"Johnell K, Religa D, Eriksdotter M: Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients. Dement Geriatr Cogn Dis. 2013, 35: 239-248. 10.1159\/000348408.","journal-title":"Dement Geriatr Cogn Dis"},{"key":"220_CR43","unstructured":"\u00c5rsrapport SveDem 2012. [http:\/\/www.ucr.uu.se\/svedem\/index.php\/om-svedem\/arsrapporter]"},{"key":"220_CR44","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research","author":"World Health Organization","year":"1993","unstructured":"World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. 1993, Geneva: WHO"},{"key":"220_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","volume":"57","author":"Clinical and neuropathological criteria for frontotemporal dementia","year":"1994","unstructured":"Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994, 57: 416-418.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"220_CR46","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/aje\/154.9.854","volume":"154","author":"S Schneeweiss","year":"2001","unstructured":"Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ: Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001, 154: 854-864. 10.1093\/aje\/154.9.854.","journal-title":"Am J Epidemiol"},{"key":"220_CR47","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00228-008-0541-3","volume":"64","author":"K Johnell","year":"2008","unstructured":"Johnell K, Fastbom J: The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study. Eur J Clin Pharmacol. 2008, 64: 1119-1124. 10.1007\/s00228-008-0541-3.","journal-title":"Eur J Clin Pharmacol"},{"key":"220_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00228-005-0079-6","volume":"62","author":"J Jyrkka","year":"2006","unstructured":"Jyrkka J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H: Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006, 62: 151-158. 10.1007\/s00228-005-0079-6.","journal-title":"Eur J Clin Pharmacol"},{"key":"220_CR49","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/eht182","volume":"34","author":"P Nordstrom","year":"2013","unstructured":"Nordstrom P, Religa D, Wimo A, Winblad B, Eriksdotter M: The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer\u2019s disease. Eur Heart J. 2013, 34: 2585-2591. 10.1093\/eurheartj\/eht182.","journal-title":"Eur Heart J"},{"key":"220_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1532-5415.2007.01522.x","volume":"56","author":"G Trifiro","year":"2008","unstructured":"Trifiro G, Morgante L, Tari M, Arcoraci V, Savica R: Burden of cardiovascular diseases in elderly with Parkinson\u2019s disease who start a dopamine agonist agent. J Am Geriatr Soc. 2008, 56: 371-373. 10.1111\/j.1532-5415.2007.01522.x.","journal-title":"J Am Geriatr Soc"},{"key":"220_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa062222","volume":"356","author":"R Schade","year":"2007","unstructured":"Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E: Dopamine agonists and the risk of cardiac-valve regurgitation. N Eng J Med. 2007, 356: 29-38. 10.1056\/NEJMoa062222.","journal-title":"N Eng J Med"},{"key":"220_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMoa054830","volume":"356","author":"R Zanettini","year":"2007","unstructured":"Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G: Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease. N Eng J Med. 2007, 356: 39-46. 10.1056\/NEJMoa054830.","journal-title":"N Eng J Med"},{"key":"220_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1179\/1743291X12Y.0000000037","volume":"21","author":"L Lethbridge","year":"2013","unstructured":"Lethbridge L, Johnston GM, Turnbull G: Co-morbidities of persons dying of Parkinson\u2019s disease. Prog Palliat Care. 2013, 21: 140-145. 10.1179\/1743291X12Y.0000000037.","journal-title":"Prog Palliat Care"},{"key":"220_CR54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0028-3843(14)60005-0","volume":"44","author":"R Magierski","year":"2010","unstructured":"Magierski R, Kloszewska I, Sobow TM: The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease. Neurol Neurochir Pol. 2010, 44: 139-147.","journal-title":"Neurol Neurochir Pol"},{"key":"220_CR55","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1212\/WNL.0b013e3182a2cbd1","volume":"81","author":"BP Boot","year":"2013","unstructured":"Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, Dickson DW, Parisi J, Aakre JA, Geda YE, Knopman DS, Petersen RC, Boeve BF: Risk factors for dementia with Lewy bodies: a case\u2013control study. Neurology. 2013, 81: 833-840. 10.1212\/WNL.0b013e3182a2cbd1.","journal-title":"Neurology"},{"key":"220_CR56","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/jama.294.6.716","volume":"294","author":"CM Boyd","year":"2005","unstructured":"Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005, 294: 716-724. 10.1001\/jama.294.6.716.","journal-title":"JAMA"},{"key":"220_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000318842","volume":"30","author":"E Sinforiani","year":"2010","unstructured":"Sinforiani E, Citterio A, Zucchella C, Bono G, Corbetta S, Merlo P, Mauri M: Impact of gender differences on the outcome of Alzheimer\u2019s disease. Dement Geriatr Cogn Dis. 2010, 30: 147-154. 10.1159\/000318842.","journal-title":"Dement Geriatr Cogn Dis"},{"key":"220_CR58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1345\/aph.1A226","volume":"36","author":"A Kennerfalk","year":"2002","unstructured":"Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S: Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother. 2002, 36: 797-803.","journal-title":"Ann Pharmacother"},{"key":"220_CR59","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archinte.162.15.1707","volume":"162","author":"KH Pitkala","year":"2002","unstructured":"Pitkala KH, Strandberg TE, Tilvis RS: Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Int Med. 2002, 162: 1707-1712. 10.1001\/archinte.162.15.1707.","journal-title":"Arch Int Med"},{"key":"220_CR60","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1345\/aph.1M147","volume":"43","author":"K Johnell","year":"2009","unstructured":"Johnell K, Weitoft GR, Fastbom J: Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother. 2009, 43: 1233-1238. 10.1345\/aph.1M147.","journal-title":"Ann Pharmacother"},{"key":"220_CR61","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.0306-5251.2001.01401.x","volume":"51","author":"I Barat","year":"2001","unstructured":"Barat I, Andreasen F, Damsgaard EM: Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001, 51: 615-622. 10.1046\/j.0306-5251.2001.01401.x.","journal-title":"Br J Clin Pharmacol"},{"key":"220_CR62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/ageing\/afr144","volume":"41","author":"JW Wastesson","year":"2012","unstructured":"Wastesson JW, Parker MG, Fastbom J, Thorslund M, Johnell K: Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study. Age Ageing. 2012, 41: 218-224. 10.1093\/ageing\/afr144.","journal-title":"Age Ageing"},{"key":"220_CR63","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/jomf.12062","volume":"75","author":"LE Pezzin","year":"2013","unstructured":"Pezzin LE, Pollak RA, Schone BS: Complex families and late-life outcomes among elderly persons: disability, institutionalization, and longevity. J. Marriage Fam. 2013, 75: 1084-1097. 10.1111\/jomf.12062.","journal-title":"J. Marriage Fam"},{"key":"220_CR64","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1471301211420331","volume":"12","author":"F Duane","year":"2013","unstructured":"Duane F, Brasher K, Koch S: Living alone with dementia. Dementia (London). 2013, 12: 123-136. 10.1177\/1471301211420331.","journal-title":"Dementia (London)"},{"key":"220_CR65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40266-012-0002-7","volume":"29","author":"K Johnell","year":"2012","unstructured":"Johnell K, Fastbom J: Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs Aging. 2012, 29: 751-758. 10.1007\/s40266-012-0002-7.","journal-title":"Drugs Aging"},{"key":"220_CR66","unstructured":"\u00c5rsrapport SveDem 2010. [http:\/\/www.ucr.uu.se\/svedem\/index.php\/om-svedem\/arsrapporter]"},{"key":"220_CR67","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/gps.2828","volume":"27","author":"A Skoldunger","year":"2012","unstructured":"Skoldunger A, Wimo A, Johnell K: Net costs of dementia in Sweden \u2013 an incidence based 10 year simulation study. Int J Geriatr Psychiatry. 2012, 27: 1112-1117. 10.1002\/gps.2828.","journal-title":"Int J Geriatr Psychiatry"},{"key":"220_CR68","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1212\/WNL.0b013e318292a2f9","volume":"80","author":"C Qiu","year":"2013","unstructured":"Qiu C, von Strauss E, Backman L, Winblad B, Fratiglioni L: Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology. 2013, 80: 1888-1894. 10.1212\/WNL.0b013e318292a2f9.","journal-title":"Neurology"},{"key":"220_CR69","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.41.12.1886","volume":"41","author":"L Fratiglioni","year":"1991","unstructured":"Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafstrom M, Holmen K, Ericsson K, Backman L, Ahlbom A, Winblad B: Prevalence of Alzheimer\u2019s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology. 1991, 41: 1886-1892. 10.1212\/WNL.41.12.1886.","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1186\/s13195-014-0063-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T00:00:00Z","timestamp":1411171200000}}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/alzrt264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/alzrt264\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/alzrt264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:26:17Z","timestamp":1728923177000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/alzrt264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,16]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,6]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1186\/alzrt264","relation":{"erratum":[{"id-type":"doi","id":"10.1186\/s13195-014-0063-4","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,16]]},"assertion":[{"value":"3 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"34"}}